Tourette Syndrome Global Clinical Trials Review, H1, 2012

Tourette Syndrome Global Clinical Trials Review, H1, 2012


March 27, 2012
72 Pages - SKU: GBDT3824178
License type:
Online Download      US $1,000.00
Global Site License      US $3,000.00
Countries covered: Global

Tourette Syndrome Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Tourette Syndrome Global Clinical Trials Review, H1, 2012 provides data on the Tourette Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tourette Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tourette Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Tourette Syndrome Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Tourette Syndrome , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.



More CNS/Neurology reports by GlobalData

MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts by GlobalData
MediPoint: Neurovascular Interventions - Global Analysis and Market ForecastsSummaryThe global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. ...
Pontine Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Pontine Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014 provides data on the Pontine Glioma ...
Malignant Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Malignant Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Glioma ...
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma ...
See all reports like this >>

More Global CNS/Neurology reports

MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts by GlobalData
MediPoint: Neurovascular Interventions - Global Analysis and Market ForecastsSummaryThe global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. ...
Pontine Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Pontine Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014 provides data on the Pontine Glioma ...
Malignant Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Malignant Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Glioma ...
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 by GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma ...
See all reports like this >>